Sign Up to like & get
recommendations!
0
Published in 2020 at "Bioscience Reports"
DOI: 10.1042/bsr20201346
Abstract: Abstract High-on treatment platelet reactivity (HTPR) leads to more prevalence of thrombotic event in patients undergoing percutaneous coronary interventions (PCI). Dual antiplatelet therapy with aspirin in addition to one P2Y12 inhibitor is commonly administrated to…
read more here.
Keywords:
high treatment;
treatment;
platelet reactivity;
platelet mapping ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Transfusion Medicine"
DOI: 10.1111/tme.12473
Abstract: The objectives of this study were to compare thromboelastography platelet mapping (TEG PM) with impedance aggregometry (Multiplate, MP) in a single trauma population and relate their results clinically.
read more here.
Keywords:
multiplate teg;
trauma;
platelet mapping;
platelet ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of neurosurgery"
DOI: 10.3171/2017.6.jns17535
Abstract: OBJECTIVEInhibition of platelet aggregation is vital to preventing thromboembolic complications related to stent placement in endovascular neurosurgery, but excessive inhibition potentiates hemorrhagic complications. Recent evidence suggests an ideal inhibition range of 70-150 P2Y12 response units…
read more here.
Keywords:
platelet inhibition;
inhibition;
pru;
platelet mapping ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2021.746024
Abstract: Background and Purpose: The purpose of the study was to evaluate the usefulness of thromboelastography with platelet mapping (TEG-PM) for predicting hematoma expansion (HE) and poor functional outcome in patients with intracerebral hemorrhage (ICH). Methods:…
read more here.
Keywords:
inhibition;
study;
thromboelastography platelet;
hemorrhage ... See more keywords